HEADER TRANSFERASE/TRANSFERASE INHIBITOR 15-NOV-16 5TX5 TITLE RIP1 KINASE ( FLAG 1-294, C34A, C127A, C233A, C240A) WITH GSK772 COMPND MOL_ID: 1; COMPND 2 MOLECULE: RECEPTOR-INTERACTING SERINE/THREONINE-PROTEIN KINASE 1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: CELL DEATH PROTEIN RIP,RECEPTOR-INTERACTING PROTEIN 1,RIP-1, COMPND 5 SERINE/THREONINE-PROTEIN KINASE RIP; COMPND 6 EC: 2.7.11.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: RIPK1, RIP, RIP1; SOURCE 6 EXPRESSION_SYSTEM: UNIDENTIFIED BACULOVIRUS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 10469 KEYWDS KINASE DOMAIN INHIBITOR NECROSIS, TRANSFERASE-TRANSFERASE INHIBITOR KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR N.CAMPOBASSO,P.WARD,J.THROPE REVDAT 2 06-MAR-24 5TX5 1 REMARK REVDAT 1 05-JUL-17 5TX5 0 JRNL AUTH P.A.HARRIS,S.B.BERGER,J.U.JEONG,R.NAGILLA,D.BANDYOPADHYAY, JRNL AUTH 2 N.CAMPOBASSO,C.A.CAPRIOTTI,J.A.COX,L.DARE,X.DONG,P.M.EIDAM, JRNL AUTH 3 J.N.FINGER,S.J.HOFFMAN,J.KANG,V.KASPARCOVA,B.W.KING,R.LEHR, JRNL AUTH 4 Y.LAN,L.K.LEISTER,J.D.LICH,T.T.MACDONALD,N.A.MILLER, JRNL AUTH 5 M.T.OUELLETTE,C.S.PAO,A.RAHMAN,M.A.REILLY,A.R.RENDINA, JRNL AUTH 6 E.J.RIVERA,M.C.SCHAEFFER,C.A.SEHON,R.R.SINGHAUS,H.H.SUN, JRNL AUTH 7 B.A.SWIFT,R.D.TOTORITIS,A.VOSSENKAMPER,P.WARD,D.D.WISNOSKI, JRNL AUTH 8 D.ZHANG,R.W.MARQUIS,P.J.GOUGH,J.BERTIN JRNL TITL DISCOVERY OF A FIRST-IN-CLASS RECEPTOR INTERACTING PROTEIN 1 JRNL TITL 2 (RIP1) KINASE SPECIFIC CLINICAL CANDIDATE (GSK2982772) FOR JRNL TITL 3 THE TREATMENT OF INFLAMMATORY DISEASES. JRNL REF J. MED. CHEM. V. 60 1247 2017 JRNL REFN ISSN 1520-4804 JRNL PMID 28151659 JRNL DOI 10.1021/ACS.JMEDCHEM.6B01751 REMARK 2 REMARK 2 RESOLUTION. 2.56 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.56 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 32.66 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.4 REMARK 3 NUMBER OF REFLECTIONS : 18588 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.200 REMARK 3 R VALUE (WORKING SET) : 0.197 REMARK 3 FREE R VALUE : 0.240 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.130 REMARK 3 FREE R VALUE TEST SET COUNT : 954 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 2.7100 - 2.5600 0.98 2820 168 0.2162 0.2670 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : NULL REMARK 3 SHRINKAGE RADIUS : NULL REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 58.19 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 55.93 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 7.56660 REMARK 3 B22 (A**2) : -3.85590 REMARK 3 B33 (A**2) : -3.71080 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.010 4278 REMARK 3 ANGLE : 1.140 5775 REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL 623 REMARK 3 DIHEDRAL : NULL 1495 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5TX5 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 16-NOV-16. REMARK 100 THE DEPOSITION ID IS D_1000224966. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-OCT-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 21-ID-D REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.078 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 325 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 18589 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.560 REMARK 200 RESOLUTION RANGE LOW (A) : 32.660 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.0 REMARK 200 DATA REDUNDANCY : 4.800 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39.42 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.03 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 23 % PEG 4000, 0.1 M AMMONIUM ACETATE REMARK 280 AND 0.1 M HEPES PH 7.5., VAPOR DIFFUSION, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 21.38700 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 64.87650 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 50.62300 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 64.87650 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 21.38700 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 50.62300 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 810 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 25760 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 3.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -8 REMARK 465 ASP A -7 REMARK 465 TYR A -6 REMARK 465 LYS A -5 REMARK 465 ASP A -4 REMARK 465 ASP A -3 REMARK 465 ASP A -2 REMARK 465 ASP A -1 REMARK 465 LYS A 0 REMARK 465 MET A 1 REMARK 465 GLN A 2 REMARK 465 PRO A 3 REMARK 465 ASP A 4 REMARK 465 MET A 5 REMARK 465 SER A 6 REMARK 465 LEU A 7 REMARK 465 ASN A 8 REMARK 465 VAL A 9 REMARK 465 GLY A 27 REMARK 465 PHE A 28 REMARK 465 ASN A 170 REMARK 465 GLU A 171 REMARK 465 GLU A 172 REMARK 465 HIS A 173 REMARK 465 ASN A 174 REMARK 465 GLU A 175 REMARK 465 LEU A 176 REMARK 465 ARG A 177 REMARK 465 GLU A 178 REMARK 465 VAL A 179 REMARK 465 ASP A 180 REMARK 465 GLY A 181 REMARK 465 THR A 182 REMARK 465 ALA A 183 REMARK 465 LYS A 184 REMARK 465 LYS A 185 REMARK 465 ASN A 186 REMARK 465 GLY A 187 REMARK 465 GLU A 229 REMARK 465 ASN A 230 REMARK 465 ALA A 231 REMARK 465 ILE A 232 REMARK 465 ALA A 233 REMARK 465 GLU A 234 REMARK 465 MET B -8 REMARK 465 ASP B -7 REMARK 465 TYR B -6 REMARK 465 LYS B -5 REMARK 465 ASP B -4 REMARK 465 ASP B -3 REMARK 465 ASP B -2 REMARK 465 ASP B -1 REMARK 465 LYS B 0 REMARK 465 MET B 1 REMARK 465 GLN B 2 REMARK 465 PRO B 3 REMARK 465 ASP B 4 REMARK 465 MET B 5 REMARK 465 SER B 6 REMARK 465 LEU B 7 REMARK 465 ASN B 8 REMARK 465 ALA B 21 REMARK 465 GLU B 22 REMARK 465 LEU B 23 REMARK 465 ASP B 24 REMARK 465 SER B 25 REMARK 465 GLY B 26 REMARK 465 GLY B 27 REMARK 465 PHE B 28 REMARK 465 GLY B 29 REMARK 465 LYS B 30 REMARK 465 VAL B 31 REMARK 465 ARG B 177 REMARK 465 GLU B 178 REMARK 465 VAL B 179 REMARK 465 ASP B 180 REMARK 465 GLY B 181 REMARK 465 THR B 182 REMARK 465 ALA B 183 REMARK 465 LYS B 184 REMARK 465 LYS B 185 REMARK 465 ASN B 186 REMARK 465 GLY B 187 REMARK 465 GLY B 188 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ILE A 10 CG1 CG2 CD1 REMARK 470 LYS A 11 CG CD CE NZ REMARK 470 GLU A 19 CG CD OE1 OE2 REMARK 470 LEU A 23 CG CD1 CD2 REMARK 470 ASP A 24 CG OD1 OD2 REMARK 470 SER A 25 OG REMARK 470 LYS A 30 CG CD CE NZ REMARK 470 GLU A 55 CG CD OE1 OE2 REMARK 470 GLU A 107 CG CD OE1 OE2 REMARK 470 MET A 108 CG SD CE REMARK 470 LYS A 167 CG CD CE NZ REMARK 470 GLN B 39 CG CD OE1 NE2 REMARK 470 GLU B 58 CG CD OE1 OE2 REMARK 470 GLU B 107 CG CD OE1 OE2 REMARK 470 MET B 108 CG SD CE REMARK 470 GLU B 172 CG CD OE1 OE2 REMARK 470 HIS B 173 CG ND1 CD2 CE1 NE2 REMARK 470 ASN B 199 CG OD1 ND2 REMARK 470 ASP B 200 CG OD1 OD2 REMARK 470 ASN B 202 CG OD1 ND2 REMARK 470 LYS B 204 CG CD CE NZ REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 ILE A 135 N CA C O CB CG1 CG2 REMARK 480 ILE A 135 CD1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 54 -34.40 -131.78 REMARK 500 GLU A 85 56.92 34.78 REMARK 500 LYS A 137 -1.21 62.33 REMARK 500 ASP A 138 27.94 -141.28 REMARK 500 PHE A 150 31.69 70.86 REMARK 500 ASP A 200 73.45 -158.61 REMARK 500 ILE B 10 64.96 -101.77 REMARK 500 THR B 38 -7.06 87.13 REMARK 500 LYS B 87 115.05 -167.24 REMARK 500 LYS B 137 -20.64 81.43 REMARK 500 GLU B 254 74.56 -119.77 REMARK 500 LEU B 293 -32.31 -130.23 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 7MJ A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 7MJ B 301 DBREF 5TX5 A 1 294 UNP Q13546 RIPK1_HUMAN 1 294 DBREF 5TX5 B 1 294 UNP Q13546 RIPK1_HUMAN 1 294 SEQADV 5TX5 MET A -8 UNP Q13546 INITIATING METHIONINE SEQADV 5TX5 ASP A -7 UNP Q13546 EXPRESSION TAG SEQADV 5TX5 TYR A -6 UNP Q13546 EXPRESSION TAG SEQADV 5TX5 LYS A -5 UNP Q13546 EXPRESSION TAG SEQADV 5TX5 ASP A -4 UNP Q13546 EXPRESSION TAG SEQADV 5TX5 ASP A -3 UNP Q13546 EXPRESSION TAG SEQADV 5TX5 ASP A -2 UNP Q13546 EXPRESSION TAG SEQADV 5TX5 ASP A -1 UNP Q13546 EXPRESSION TAG SEQADV 5TX5 LYS A 0 UNP Q13546 EXPRESSION TAG SEQADV 5TX5 ALA A 34 UNP Q13546 CYS 34 ENGINEERED MUTATION SEQADV 5TX5 ALA A 127 UNP Q13546 CYS 127 ENGINEERED MUTATION SEQADV 5TX5 ALA A 233 UNP Q13546 CYS 233 ENGINEERED MUTATION SEQADV 5TX5 ALA A 240 UNP Q13546 CYS 240 ENGINEERED MUTATION SEQADV 5TX5 MET B -8 UNP Q13546 INITIATING METHIONINE SEQADV 5TX5 ASP B -7 UNP Q13546 EXPRESSION TAG SEQADV 5TX5 TYR B -6 UNP Q13546 EXPRESSION TAG SEQADV 5TX5 LYS B -5 UNP Q13546 EXPRESSION TAG SEQADV 5TX5 ASP B -4 UNP Q13546 EXPRESSION TAG SEQADV 5TX5 ASP B -3 UNP Q13546 EXPRESSION TAG SEQADV 5TX5 ASP B -2 UNP Q13546 EXPRESSION TAG SEQADV 5TX5 ASP B -1 UNP Q13546 EXPRESSION TAG SEQADV 5TX5 LYS B 0 UNP Q13546 EXPRESSION TAG SEQADV 5TX5 ALA B 34 UNP Q13546 CYS 34 ENGINEERED MUTATION SEQADV 5TX5 ALA B 127 UNP Q13546 CYS 127 ENGINEERED MUTATION SEQADV 5TX5 ALA B 233 UNP Q13546 CYS 233 ENGINEERED MUTATION SEQADV 5TX5 ALA B 240 UNP Q13546 CYS 240 ENGINEERED MUTATION SEQRES 1 A 303 MET ASP TYR LYS ASP ASP ASP ASP LYS MET GLN PRO ASP SEQRES 2 A 303 MET SER LEU ASN VAL ILE LYS MET LYS SER SER ASP PHE SEQRES 3 A 303 LEU GLU SER ALA GLU LEU ASP SER GLY GLY PHE GLY LYS SEQRES 4 A 303 VAL SER LEU ALA PHE HIS ARG THR GLN GLY LEU MET ILE SEQRES 5 A 303 MET LYS THR VAL TYR LYS GLY PRO ASN CYS ILE GLU HIS SEQRES 6 A 303 ASN GLU ALA LEU LEU GLU GLU ALA LYS MET MET ASN ARG SEQRES 7 A 303 LEU ARG HIS SER ARG VAL VAL LYS LEU LEU GLY VAL ILE SEQRES 8 A 303 ILE GLU GLU GLY LYS TYR SER LEU VAL MET GLU TYR MET SEQRES 9 A 303 GLU LYS GLY ASN LEU MET HIS VAL LEU LYS ALA GLU MET SEQRES 10 A 303 SER THR PRO LEU SER VAL LYS GLY ARG ILE ILE LEU GLU SEQRES 11 A 303 ILE ILE GLU GLY MET ALA TYR LEU HIS GLY LYS GLY VAL SEQRES 12 A 303 ILE HIS LYS ASP LEU LYS PRO GLU ASN ILE LEU VAL ASP SEQRES 13 A 303 ASN ASP PHE HIS ILE LYS ILE ALA ASP LEU GLY LEU ALA SEQRES 14 A 303 SER PHE LYS MET TRP SER LYS LEU ASN ASN GLU GLU HIS SEQRES 15 A 303 ASN GLU LEU ARG GLU VAL ASP GLY THR ALA LYS LYS ASN SEQRES 16 A 303 GLY GLY THR LEU TYR TYR MET ALA PRO GLU HIS LEU ASN SEQRES 17 A 303 ASP VAL ASN ALA LYS PRO THR GLU LYS SER ASP VAL TYR SEQRES 18 A 303 SER PHE ALA VAL VAL LEU TRP ALA ILE PHE ALA ASN LYS SEQRES 19 A 303 GLU PRO TYR GLU ASN ALA ILE ALA GLU GLN GLN LEU ILE SEQRES 20 A 303 MET ALA ILE LYS SER GLY ASN ARG PRO ASP VAL ASP ASP SEQRES 21 A 303 ILE THR GLU TYR CYS PRO ARG GLU ILE ILE SER LEU MET SEQRES 22 A 303 LYS LEU CYS TRP GLU ALA ASN PRO GLU ALA ARG PRO THR SEQRES 23 A 303 PHE PRO GLY ILE GLU GLU LYS PHE ARG PRO PHE TYR LEU SEQRES 24 A 303 SER GLN LEU GLU SEQRES 1 B 303 MET ASP TYR LYS ASP ASP ASP ASP LYS MET GLN PRO ASP SEQRES 2 B 303 MET SER LEU ASN VAL ILE LYS MET LYS SER SER ASP PHE SEQRES 3 B 303 LEU GLU SER ALA GLU LEU ASP SER GLY GLY PHE GLY LYS SEQRES 4 B 303 VAL SER LEU ALA PHE HIS ARG THR GLN GLY LEU MET ILE SEQRES 5 B 303 MET LYS THR VAL TYR LYS GLY PRO ASN CYS ILE GLU HIS SEQRES 6 B 303 ASN GLU ALA LEU LEU GLU GLU ALA LYS MET MET ASN ARG SEQRES 7 B 303 LEU ARG HIS SER ARG VAL VAL LYS LEU LEU GLY VAL ILE SEQRES 8 B 303 ILE GLU GLU GLY LYS TYR SER LEU VAL MET GLU TYR MET SEQRES 9 B 303 GLU LYS GLY ASN LEU MET HIS VAL LEU LYS ALA GLU MET SEQRES 10 B 303 SER THR PRO LEU SER VAL LYS GLY ARG ILE ILE LEU GLU SEQRES 11 B 303 ILE ILE GLU GLY MET ALA TYR LEU HIS GLY LYS GLY VAL SEQRES 12 B 303 ILE HIS LYS ASP LEU LYS PRO GLU ASN ILE LEU VAL ASP SEQRES 13 B 303 ASN ASP PHE HIS ILE LYS ILE ALA ASP LEU GLY LEU ALA SEQRES 14 B 303 SER PHE LYS MET TRP SER LYS LEU ASN ASN GLU GLU HIS SEQRES 15 B 303 ASN GLU LEU ARG GLU VAL ASP GLY THR ALA LYS LYS ASN SEQRES 16 B 303 GLY GLY THR LEU TYR TYR MET ALA PRO GLU HIS LEU ASN SEQRES 17 B 303 ASP VAL ASN ALA LYS PRO THR GLU LYS SER ASP VAL TYR SEQRES 18 B 303 SER PHE ALA VAL VAL LEU TRP ALA ILE PHE ALA ASN LYS SEQRES 19 B 303 GLU PRO TYR GLU ASN ALA ILE ALA GLU GLN GLN LEU ILE SEQRES 20 B 303 MET ALA ILE LYS SER GLY ASN ARG PRO ASP VAL ASP ASP SEQRES 21 B 303 ILE THR GLU TYR CYS PRO ARG GLU ILE ILE SER LEU MET SEQRES 22 B 303 LYS LEU CYS TRP GLU ALA ASN PRO GLU ALA ARG PRO THR SEQRES 23 B 303 PHE PRO GLY ILE GLU GLU LYS PHE ARG PRO PHE TYR LEU SEQRES 24 B 303 SER GLN LEU GLU HET 7MJ A 301 28 HET 7MJ B 301 28 HETNAM 7MJ 3-BENZYL-N-[(3S)-5-METHYL-4-OXO-2,3,4,5-TETRAHYDRO-1,5- HETNAM 2 7MJ BENZOXAZEPIN-3-YL]-1H-1,2,4-TRIAZOLE-5-CARBOXAMIDE FORMUL 3 7MJ 2(C20 H19 N5 O3) FORMUL 5 HOH *34(H2 O) HELIX 1 AA1 LYS A 13 SER A 15 5 3 HELIX 2 AA2 HIS A 56 ARG A 69 1 14 HELIX 3 AA3 ASN A 99 LYS A 105 1 7 HELIX 4 AA4 PRO A 111 LYS A 132 1 22 HELIX 5 AA5 LYS A 140 GLU A 142 5 3 HELIX 6 AA6 PHE A 162 LEU A 168 1 7 HELIX 7 AA7 THR A 206 ASN A 224 1 19 HELIX 8 AA8 GLN A 236 GLY A 244 1 9 HELIX 9 AA9 ASP A 248 ILE A 252 5 5 HELIX 10 AB1 PRO A 257 TRP A 268 1 12 HELIX 11 AB2 THR A 277 LEU A 293 1 17 HELIX 12 AB3 LYS B 13 PHE B 17 5 5 HELIX 13 AB4 CYS B 53 ARG B 69 1 17 HELIX 14 AB5 LEU B 100 LYS B 105 1 6 HELIX 15 AB6 PRO B 111 LYS B 132 1 22 HELIX 16 AB7 LYS B 140 GLU B 142 5 3 HELIX 17 AB8 PHE B 162 ASN B 169 1 8 HELIX 18 AB9 THR B 189 MET B 193 5 5 HELIX 19 AC1 ALA B 194 ASN B 199 1 6 HELIX 20 AC2 THR B 206 ASN B 224 1 19 HELIX 21 AC3 ALA B 233 SER B 243 1 11 HELIX 22 AC4 ASP B 248 THR B 253 5 6 HELIX 23 AC5 PRO B 257 TRP B 268 1 12 HELIX 24 AC6 ASN B 271 ARG B 275 5 5 HELIX 25 AC7 THR B 277 LEU B 293 1 17 SHEET 1 AA1 6 LYS A 11 MET A 12 0 SHEET 2 AA1 6 LEU A 78 ILE A 83 1 O VAL A 81 N MET A 12 SHEET 3 AA1 6 LYS A 87 GLU A 93 -1 O SER A 89 N ILE A 82 SHEET 4 AA1 6 GLY A 40 LYS A 49 -1 N ILE A 43 O MET A 92 SHEET 5 AA1 6 VAL A 31 HIS A 36 -1 N SER A 32 O MET A 44 SHEET 6 AA1 6 PHE A 17 LEU A 23 -1 N ALA A 21 O LEU A 33 SHEET 1 AA2 2 ILE A 144 VAL A 146 0 SHEET 2 AA2 2 ILE A 152 ILE A 154 -1 O LYS A 153 N LEU A 145 SHEET 1 AA3 4 LEU B 33 HIS B 36 0 SHEET 2 AA3 4 GLY B 40 TYR B 48 -1 O MET B 42 N ALA B 34 SHEET 3 AA3 4 LYS B 87 GLU B 93 -1 O TYR B 88 N VAL B 47 SHEET 4 AA3 4 LEU B 78 GLU B 84 -1 N GLY B 80 O VAL B 91 SHEET 1 AA4 3 GLY B 98 ASN B 99 0 SHEET 2 AA4 3 ILE B 144 VAL B 146 -1 O VAL B 146 N GLY B 98 SHEET 3 AA4 3 ILE B 152 ILE B 154 -1 O LYS B 153 N LEU B 145 CISPEP 1 GLU B 254 TYR B 255 0 -8.16 SITE 1 AC1 15 VAL A 31 LYS A 45 MET A 67 VAL A 76 SITE 2 AC1 15 LEU A 78 LEU A 90 MET A 92 HIS A 136 SITE 3 AC1 15 ILE A 154 ALA A 155 ASP A 156 LEU A 157 SITE 4 AC1 15 LEU A 159 PHE A 162 HOH A 403 SITE 1 AC2 14 ILE B 43 LYS B 45 LEU B 70 VAL B 76 SITE 2 AC2 14 LEU B 78 LEU B 90 MET B 92 HIS B 136 SITE 3 AC2 14 ILE B 154 ALA B 155 ASP B 156 LEU B 157 SITE 4 AC2 14 PHE B 162 HOH B 403 CRYST1 42.774 101.246 129.753 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023379 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009877 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007707 0.00000